Rise in broadly cross-reactive adaptive immunity against human beta-coronaviruses in MERS-recovered patients during the COVID-19 pandemic
Description
To develop a universal coronavirus (CoV) vaccine, long-term immunity against multiple CoVs, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, Middle East respiratory syndrome (MERS)-CoV, and future CoV strains, is
